Equity research Viva Wine Group: Positive profitability trend should continue in Q4 2024
20 Jan 2025
Viva Wine Group (the company or Viva) will release its Q4 2024 report on 20 February 2025. Below are Carlsquare Equity Research’s updated estimates ahead of the report.
- Based on sales statistics from the Finnish and Norwegian markets, we expect wine volumes in the Nordic monopolies to have declined also in Q4, mainly driven by slow sales in Alko stores (Finland) due to the migration to the grocery channel. However, we assume a more stable Swedish market to mitigate the slowdown.
- We remain confident of growth in Viva’s Nordics segment due to market share gains during 2024, price adjustments, and good performance in the Finnish grocery channel. In fact, with fewer market headwinds, we raise our expectations for the Nordics segment in 2024 somewhat.
- The development for Viva e-com is harder to estimate given the “bumpiness” of recent quarters, slow markets, and still low consumer confidence in, for example, Germany. As we see no apparent signs of an upturn, we adopt a more cautious view in the short term and expect another quarter of lower demand.
- We revise our total net sales estimate for Viva Wine Group, including the Other segment and eliminations, in Q4 2024 upwards to SEK 1,151m (from SEK 1,134m previously), corresponding to a growth of 4.8 per cent.
- Viva Wine Group has guided for a sequentially improved gross margin (Q3: 20.6 per cent) and stable operating costs y-o-y. We assume an OPEX of SEK 141m in the past quarter. This supports our view of a continued robust profitability trend.
- For the group, we expect an adjusted EBITA of SEK 106m (70), corresponding to a margin of 9.2% (6.3).
- We will review our current base case valuation of SEK 51 per share in conjunction with the Q4 report. We believe the share price decline since the release of the Q3 2024 report is unwarranted and probably explained by a weak performance for the alcoholic beverages sector in general. Thus, we see a good opportunity for a rebound in the share price in the run-up to the Q4 report on 20 February.
Read the latest research update here.
Disclaimer
Carlsquare AB, www.carlsquare.se, hereinafter referred to as Carlsquare, is engaged in corporate finance and equity research, publishing information on companies and including analyses. The information has been compiled from sources that Carlsquare deems reliable. However, Carlsquare cannot guarantee the accuracy of the information. Nothing written in the analysis should be considered a recommendation or solicitation to invest in any financial instrument, option, or the like. Opinions and conclusions expressed in the analysis are intended solely for the recipient.
The content may not be copied, reproduced, or distributed to any other person without the written consent of Carlsquare. Carlsquare shall not be liable for either direct or indirect damages caused by decisions made on the basis of information contained in this analysis. Investments in financial instruments offer the potential for appreciation and gains. All such investments are also subject to risks. The risks vary between different types of financial instruments and combinations thereof. Past performance should not be taken as an indication of future returns.
The analysis is not directed at U.S. Persons (as that term is defined in Regulation S under the United States Securities Act and interpreted in the United States Investment Companies Act of 1940), nor may it be disseminated to such persons. The analysis is not directed at natural or legal persons where the distribution of the analysis to such persons would involve or entail a risk of violation of Swedish or foreign laws or regulations.
The analysis is a so-called Assignment Analysis for which the analysed company has signed an agreement with Carlsquare for analysis coverage. The analyses are published on an ongoing basis during the contract period and for the usually fixed fee.
Carlsquare may or may not have a financial interest with respect to the subject matter of this analysis. Carlsquare values the assurance of objectivity and independence and has established procedures for managing conflicts of interest for this purpose.
The analysts Markus Augustsson and Niklas Elmhammer do not own and may not own shares in the analysed company.